Home > Quotes > GALE

Galena Biopharma, Inc. Common Stock Quote & Summary Data

Get GALE Alerts
*Delayed - data as of Apr. 29, 2016  -  Find a broker to begin trading GALE now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    GALE After Hours
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Galena Biopharma, Inc. Common Stock Intraday Chart

News for GALE

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 1.46 $ 2.39
Low $ 1.3799 $ 0.5855

The current last sale of $1.38 is 135.70% Higher thanthe 52 week low.

P/E Ratio

Company Description (as filed with the SEC)

Galena Biopharma, Inc. ("we," "us," "our," "Galena" or the "Company") is a biopharmaceutical company committed to the development and commercialization of targeted oncology therapeutics that address major unmet medical needs. Galena's development portfolio is focused primarily on addressing the rapidly growing patient populations of cancer survivors by harnessing the power of the immune system to prevent cancer recurrence. The Company's pipeline consists of multiple mid- to late-stage clinical assets, including novel cancer immunotherapy programs led by NeuVax(TM) (nelipepimut-S), GALE-301 and GALE-302. NeuVax is currently in a pivotal, Phase 3 breast cancer clinical trial with several concurrent Phase 2 trials ongoing both as a single agent and in combination with other therapies. GALE-301 is in a Phase 2a clinical trial in ovarian and endometrial cancers and in a Phase 1b clinical trial given sequentially with GALE-302.  ... More ...  

Risk Grade

Where does GALE fit in the risk graph?

Risk Grade Scale

Nasdaq Official Price

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?